ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 2938 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
 


 

 
     
    Advanced search
 

 
 
     
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1309    
    Printed9    
    Emailed0    
    PDF Downloaded147    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents
LETTER TO EDITOR  
Year : 2015  |  Volume : 18  |  Issue : 4  |  Page : 577-578
Role of phenoxybenzamine in perioperative clinical practice


Department of Cardiac Anaesthesia, All India Institute of Medical Sciences, New Delhi, India

Click here for correspondence address and email

Date of Web Publication1-Oct-2015
 

How to cite this article:
Sambhunath D, Pankaj K, Usha K. Role of phenoxybenzamine in perioperative clinical practice. Ann Card Anaesth 2015;18:577-8

How to cite this URL:
Sambhunath D, Pankaj K, Usha K. Role of phenoxybenzamine in perioperative clinical practice. Ann Card Anaesth [serial online] 2015 [cited 2020 Feb 24];18:577-8. Available from: http://www.annals.in/text.asp?2015/18/4/577/166473


The Editor,

Phenoxybenzamine (PBZ) is a long-acting α-adrenergic receptor blocking drug. [1] It is a haloalkylamine derivative, chemically related to nitrogen mustard, and the molecular configuration responsible for the blockade is a highly reactive carbonium ion formed on cleavage of the tertiary amine ring.

PBZ is recommended for the treatment of malignant hypertension in situations such as pheochromocytoma. Preoperatively, PBZ aids in the control of blood pressure, permits correction of the contracted plasma volume, and protects against catecholamine-induced cardiac damage. [2] The use of PBZ is now limited by shorter acting alpha blocking drugs. Subsequently, PBZ was used with promising better improvement of systemic oxygen delivery and balancing the pulmonary to systemic blood flow by reducing the systemic vascular resistance in hypoplastic left heart syndrome undergoing Norwood procedure. [3] This is still practiced by many centers. The uses of PBZ have further extended to hypotensive anesthesia, prevent spasm in radial artery before grafting in coronary artery bypass surgery, causalgia, Raynaud's phenomenon, and autonomic hyperreflexia. [4],[5] However, prolonged hypotension and reflex tachycardia from PBZ created dilemma in the minds of physicians.

The use of PBZ during pediatric cardiac surgery facilitates higher pump flow during cardiopulmonary bypass (CPB) and is associated with less metabolic acidosis postoperatively. [6],[7] In addition, PBZ was found to be more effective than sodium nitroprusside in improving tissue perfusion after CPB. [8] The neonatal heart is more susceptible to exogenous catecholamine-induced cardiotoxicity. [9] Hence, vasodilatory therapy can play a key role in improving cardiac output by decreasing afterload without affecting the contractility. A combination of PBZ and NTG is a low-cost alternative for perioperative control of pulmonary arterial pressure by reducing the pulmonary blood flow from vasodilation thereby decreasing the right ventricular load. [10] In authors' institution, PBZ is used in perioperative hemodynamic management of neonatal, congenital, and conditions with increased Qp cardiac surgical patients with better outcome. [7],[10],[11]

Hypotension and tachycardia due to PBZ can be managed with adequate preload, proper dosing, and alternative vasoconstrictor. When exogenous sympathomimetics are administered after α blockade from PBZ, their vasoconstrictive effect is inhibited resulting in exaggerated vasodilatory effect. This is most commonly found with the use of adrenaline/epinephrine after PBZ. Epinephrine administration cause severe hypotension, low cardiac output, and tachycardia because of the refractory α-receptor blockade and unopposed ί-receptor activity. [1] The recommended treatment of PBZ-induced hypotension is norepinephrine infusion because some of the receptors remain free of the drug. Vasopressin is an effective antidote for PBZ-induced vasodilation. Vasopressin acts on smooth muscle V1 receptors and is able to overcome its effect. [12]

In summary, PBZ has a therapeutic role for the treatment of hypertension in pheochromocytoma, control of systemic vascular resistance in congenital heart surgery, and balancing the pulmonary to systemic blood flow in severe pulmonary hypertension. It offers convenient and versatile dosing because of the oral and parenteral administration. The intraoperative, postoperative, and intensive care setting use is safe with continuous hemodynamic monitoring and delivers the best results with excellent outcome in specific conditions. The potent hypotensive effects alarm the judicious and titrated use of PBZ.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Westfall TC, Westfall DP. Adrenergic Agonists and Antagonists. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 12 th ed. USA: McGraw-Hill Companies, Inc.; 2011. p. 148-87.  Back to cited text no. 1
    
2.
Prys-Roberts C. Phaeochromocytoma - Recent progress in its management. Br J Anaesth 2000;85:44-57.  Back to cited text no. 2
    
3.
Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: Lessons learned from 115 consecutive patients. Circulation 2002;106 12 Suppl 1:I82-9.  Back to cited text no. 3
    
4.
Brown TC. Early experiences of vasodilators and hypotensive anesthesia in children. Paediatr Anaesth 2012;22:720-2.  Back to cited text no. 4
    
5.
Kulik A, Rubens FD, Gunning D, Bourke ME, Mesana TG, Ruel M. Radial artery graft treatment with phenoxybenzamine is clinically safe and may reduce perioperative myocardial injury. Ann Thorac Surg 2007;83:502-9.  Back to cited text no. 5
    
6.
Mossad E, Motta P, Sehmbey K, Toscana D. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children. J Clin Anesth 2008;20:94-8.  Back to cited text no. 6
    
7.
Bisoi AK, Sharma P, Chauhan S, Reddy SM, Das S, Saxena A, et al. Primary arterial switch operation in children presenting late with d-transposition of great arteries and intact ventricular septum. When is it too late for a primary arterial switch operation? Eur J Cardiothorac Surg 2010;38:707-13.  Back to cited text no. 7
    
8.
Motta P, Mossad E, Toscana D, Zestos M, Mee R. Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. J Cardiothorac Vasc Anesth 2005;19:54-9.  Back to cited text no. 8
    
9.
Caspi J, Coles JG, Benson LN, Herman SL, Diaz RJ, Augustine J, et al. Age-related response to epinephrine-induced myocardial stress. A functional and ultrastructural study. Circulation 1991;84 5 Suppl: III394-9.  Back to cited text no. 9
    
10.
Kiran U, Makhija N, Das SN, Bhan A, Airan B. Combination of phenoxybenzamine and nitroglycerin: Effective control of pulmonary artery pressures in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2005;19:274-5.  Back to cited text no. 10
    
11.
Das S, Nanda S, Bisoi AK, Makhija N. Effects of two different doses of phenoxybenzamine during cardiopulmonary bypass in infants undergoing arterial switch operation for transposition of great arteries. J Cardiovasc Surg Med 2015;1:17-21.  Back to cited text no. 11
    
12.
O'Blenes SB, Roy N, Konstantinov I, Bohn D, Van Arsdell GS. Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure. J Thorac Cardiovasc Surg 2002;123:1012-3.  Back to cited text no. 12
    

Top
Correspondence Address:
Das Sambhunath
Department of Cardiac Anaesthesia, 7th Floor, Cardio Thoracic Sciences Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.166473

Rights and Permissions




 

Top